content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
  <submissionType>144</submissionType>
  <filerInfo>
  <filer>
  <filerCredentials>
  <cik>0002042910</cik>
  <ccc>XXXXXXXX</ccc>
  </filerCredentials>
  </filer>
  <liveTestFlag>LIVE</liveTestFlag>
  </filerInfo>
  </headerData>
  <formData>
  <issuerInfo>
  <issuerCik>0001501796</issuerCik>
  <issuerName>Aura Biosciences, Inc. </issuerName>
  <secFileNumber>001-40971</secFileNumber>
  <issuerAddress>
  <street1 xmlns="http://www.sec.gov/edgar/common">80 Guest Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">Boston</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">02135</zipCode>
  </issuerAddress>
  <issuerContactPhone>617-500-8864</issuerContactPhone>
  <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Elazzouzi Amy</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
  <relationshipsToIssuer>
  <relationshipToIssuer>Officer</relationshipToIssuer>
  </relationshipsToIssuer>
  </issuerInfo>
  <securitiesInformation>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <brokerOrMarketmakerDetails>
  <name>Morgan Stanley Smith Barney LLC Drive</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">200 West Civic Center</street1>
  <street2 xmlns="http://www.sec.gov/edgar/common">4th Floor</street2>
  <city xmlns="http://www.sec.gov/edgar/common">Sandy</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">UT</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">84070</zipCode>
  </address>
  </brokerOrMarketmakerDetails>
  <noOfUnitsSold>897</noOfUnitsSold>
  <aggregateMarketValue>4925.25</aggregateMarketValue>
  <noOfUnitsOutstanding>50225312</noOfUnitsOutstanding>
  <approxSaleDate>04/16/2025</approxSaleDate>
  <securitiesExchangeName>Nasdaq</securitiesExchangeName>
  </securitiesInformation>
  <securitiesToBeSold>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <acquiredDate>04/03/2023</acquiredDate>
  <natureOfAcquisitionTransaction>Restricted Stock unit award granted pursuant to the Issuer's 2021 Stock Option and Incentive Plan, subject to vesting requirements.</natureOfAcquisitionTransaction>
  <nameOfPersonfromWhomAcquired>Aura Biosciences, Inc.</nameOfPersonfromWhomAcquired>
  <isGiftTransaction>N</isGiftTransaction>
  <amountOfSecuritiesAcquired>3000</amountOfSecuritiesAcquired>
  <paymentDate>04/03/2023</paymentDate>
  <natureOfPayment>N/A</natureOfPayment>
  </securitiesToBeSold>
  <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Amy Elazzouzi</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">80 Guest Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">Boston</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">02135</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>01/21/2025</saleDate>
  <amountOfSecuritiesSold>1001</amountOfSecuritiesSold>
  <grossProceeds>7679.15</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Amy Elazzouzi</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">80 Guest Street</street1>
  <city xmlns="http://www.sec.gov/edgar/common">Boston</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">02135</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common Stock</securitiesClassTitle>
  <saleDate>02/18/2025</saleDate>
  <amountOfSecuritiesSold>1404</amountOfSecuritiesSold>
  <grossProceeds>10881.14</grossProceeds>
  </securitiesSoldInPast3Months>
  <remarks>The sales reported on this Form 144 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.</remarks>
  <noticeSignature>
  <noticeDate>04/16/2025</noticeDate>
  <signature>Amy Elazzouzi</signature>
  </noticeSignature>
  </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4347}]
text: 144
  0002042910
  XXXXXXXX
  LIVE
  0001501796
  Aura Biosciences, Inc.
  001-40971
  80 Guest Street
  Boston
  MA
  02135
  617-500-8864
  Elazzouzi Amy
  Officer
  Common Stock
  Morgan Stanley Smith Barney LLC Drive
  200 West Civic Center
  4th Floor
  Sandy
  UT
  84070
  897
  4925.25
  50225312
  04/16/2025
  Nasdaq
  Common Stock
  04/03/2023
  Restricted Stock unit award granted pursuant to the Issuer's 2021 Stock Option and Incentive Plan, subject to vesting requirements.
  Aura Biosciences, Inc.
  N
  3000
  04/03/2023
  N/A
  N
  Amy Elazzouzi
  80 Guest Street
  Boston
  MA
  02135
  Common Stock
  01/21/2025
  1001
  7679.15
  Amy Elazzouzi
  80 Guest Street
  Boston
  MA
  02135
  Common Stock
  02/18/2025
  1404
  10881.14
  The sales reported on this Form 144 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
  04/16/2025
  Amy Elazzouzi